Sientra, a Santa Barbara medical device company focused on plastic surgery and aesthetics medicine, said it raised a $85 million second round of financing — one of the largest private funding rounds in the medical device sector.
Sientra also announced that it has acquired the assets of Silimed Inc., a leading developer of plastic surgery implants for both cosmetic and reconstructive surgery.
[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":6623,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"business,","session":"A"}']The round was co-led by OrbiMed Advisors and Clarus Ventures, and included Goldman Sachs and TIAA-CREF.
Sientra plans to use some of the proceeds to finance the Silimed acquisition.
AI Weekly
The must-read newsletter for AI and Big Data industry written by Khari Johnson, Kyle Wiggers, and Seth Colaner.
Included with VentureBeat Insider and VentureBeat VIP memberships.
Statement is here. We couldn’t find a Web site for Sientra.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn More